Oxygen Therapy Market Size, Share & Trends Analysis Report By Product (Oxygen Source Equipment, Oxygen Delivery Devices), By Application, By End-use (Home Healthcare, Non-Home Healthcare), By Region, And Segment Forecasts, 2024 - 2030

Oxygen Therapy Market Size, Share & Trends Analysis Report By Product (Oxygen Source Equipment, Oxygen Delivery Devices), By Application, By End-use (Home Healthcare, Non-Home Healthcare), By Region, And Segment Forecasts, 2024 - 2030


Oxygen Therapy Market Growth & Trends

The global oxygen therapy market size is expected to reach USD 54.14 billion by 2030, according to a new report by Grand View Research Inc., expanding at a CAGR of 6.83% from 2024 to 2030. The increasing prevalence of major respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and obstructive sleep apnea, is a high-impact rendering driver of the market. As per the estimates of the WHO, a consequential global rise in the prevalence of asthma and other respiratory disorders is expected to heighten clinical urgency to treat the aforementioned disorders and is expected to boost the demand for oxygen therapy as the first-line treatment and as a supplement in various applications.

Moreover, technological advancements are anticipated to provide growth opportunities in a wide range of new applications such as cancer and diabetes. For instance, incorporation of flow sensors in delivery devices to conserve and regulate the flow enables greater patient comfort and outcomes. Furthermore, the increasing focus on home healthcare solutions, coupled with the development of portable delivery devices, is significantly impacting industry growth. These aforementioned factors are expected to serve as key factors contributing to the growth of the market over the forecast period.

The Covid-19 pandemic has positively impacted the market for O2 therapy devices. Due to the outbreak, oxygen demand has increased significantly, especially during the spikes in patients at hospitals suffering from Covid-19. Additionally, pressure on oxygen supplies at hospitals has been caused by a large number of Covid-19 patients. Therefore, the demand for O2 therapy devices in the healthcare sector has increased and will continue to increase significantly in the near future. The governments of various countries are focusing on expanding healthcare facilities in rural areas. With the upcoming infrastructural projects, the demand for medical O2 is expected to increase substantially.

Oxygen Therapy Market Report Highlights
  • The oxygen source equipment segment held the largest share in 2023 owing to its high usage rate and wide-scale availability in various forms such as liquid compressed gas, and concentrators
  • Oxygen delivery devices are expected to grow at a lucrative rate being an indispensable part of the oxygen therapy set-ups, thereby contributing to the overall market growth during the forecast period
  • Oxygen concentrators captured a dominant share in 2023 owing to rising popularity and adoption of portable concentrators in emergency medicine, ambulatory, and home settings
  • Oxygen masks accounted for a leading share in 2023 as a consequence of being the indispensable unit of the delivery system and greater availability of specialty masks as per the patient’s physiological needs
  • Home healthcare is anticipated to grow lucratively owing to associated benefits such as long-term cost efficiency and increased mobility, propelling the demand over the forecast period
  • Moreover, the presence of organizations such as the American Association for Homecare to promote awareness and strengthen home healthcare is expected to provide growth opportunities to the market in the future
  • Industry players are adopting strategies such as new product development, technological innovations, collaborations, and mergers & acquisitions to acquire a greater market share
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR's Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information/Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.2 Top Down Market Estimation
1.6.3 Region Based Segment Share Calculation
1.6.4 Global Market: CAGR Calculation
1.7 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Oxygen Therapy Market Summary
2.1.1 Segment Outlook
2.1.2 Regional Outlook
2.1.3 Competitive Outlook
2.2 Market Snapshot, 2023
Chapter 3 Oxygen Therapy Market Variables Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Segment Scope
3.2 Market Lineage Outlook
3.2.1 Ancillary Market Outlook
3.3 Penetration & Growth Prospect Mapping
3.4 Regulatory Framework
3.4.1 Europe
3.4.1.1 UK
3.4.2 North America
3.4.2.1 U.S.
3.4.2.2 Canada
3.4.3 Asia Pacific
3.4.3.1 India
3.4.3.2 China
3.4.3.3 Australia
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Rising Prevalence of Respiratory Diseases
3.5.1.2 Launch of New Generation Product and Increasing Business Expansion
3.5.1.3 Growing Preference Towards Home-Based Oxygen Therapy
3.5.1.4 Rising Initiative By Organizations Regarding Respiratory Diseases
3.5.2 Market Restraints Analysis
3.5.2.1 Complex Regulatory Framework
3.6 Oxygen Therapy Market Analysis Tools: Porter’s
3.6.1 Bargaining Power of Suppliers: Low
3.6.2 Bargaining Power of Buyers: High
3.6.3 Threat of Substitutes: High
3.6.4 Threat of New Entrants: High
3.6.5 Industry Rivalry: High
3.7 PESTEL Analysis
3.7.1 Political & Legal
3.7.2 Economic
3.7.3 Social
3.7.4 Technological
3.7.5 Environmental
3.8 COVID-19 Current and Future Impact Analysis
3.8.1 Current Impact Analysis
3.8.2 Future Impact Analysis
3.8.3 COVID-19 Impact On Notable Market Players
3.8.3.1 Philips N.V.
3.8.3.2 Fisher & Paykel Healthcare
3.8.3.3 GE Healthcare
Chapter 4 Oxygen Therapy Market: Product Estimates & Trend Analysis
4.1 Product Movement Analysis, 2018 - 2030 (USD Million)
4.2 Oxygen Therapy Market Share Analysis, 2023 & 2030
4.3 Oxygen Source Equipment
4.3.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2 Oxygen Cylinders
4.3.2.1 Market Insight
4.3.2.2 Competitive Insight
4.3.2.3 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.4 Fixed Oxygen Cylinders
4.3.2.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.5 Portable Oxygen Cylinders
4.3.2.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3 Oxygen Concentrator
4.3.3.1 Market Insight
4.3.3.2 Competitive Insight
4.3.3.3 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.4 Fixed Oxygen Concentrator
4.3.3.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.5 Portable Oxygen Concentrator
4.3.3.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4 Liquid Oxygen System
4.3.4.1 Market Insight
4.3.4.2 Competitive Insight
4.3.4.3 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5 PAP Devices
4.3.5.1 Market Insight
4.3.5.2 Competitive Insight
4.3.5.3 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5.4 CPAP Devices
4.3.5.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5.5 APAP Devices
4.3.5.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5.6 Bi-PAP Devices
4.3.5.6.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4 Oxygen Delivery Devices
4.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2 Oxygen Mask
4.4.2.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3 Nasal Cannula
4.4.3.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4 Venturi Mask
4.4.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5 Non-Rebreather Mask
4.4.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.6 Bag Valve Mask
4.4.6.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.7 CPAP Mask
4.4.7.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.8 Others
4.4.8.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5 Oxygen Therapy Market: Application Estimates & Trend Analysis
5.1 Application Movement Analysis, 2018 - 2030 (USD Million)
5.2 Oxygen Therapy Market Share Analysis, 2022 & 2030
5.3 Chronic Obstructive Pulmonary Disease
5.3.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4 Asthma
5.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5 Obstructive Sleep Apnea
5.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6 Respiratory Distress Syndrome
5.6.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7 Cystic Fibrosis
5.7.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8 Pneumonia
5.8.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9 Others
5.9.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6: Oxygen Therapy Market: End Use Estimates & Trend Analysis
6.1 End use Movement Analysis, 2018 - 2030 (USD Million)
6.2 Oxygen Therapy Market Share Analysis, 2022 & 2030
6.3 Homecare
6.3.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4 Non-Homecare
6.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7: Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)
7.1 Regional Market Snapshot
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 North America
7.3.1 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3 Canada
7.3.3.1 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4 Mexico
7.3.4.1 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4 Europe
7.4.1 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2 Germany
7.4.2.1 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3 France
7.4.3.1 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4 UK
7.4.4.1 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5 Italy
7.4.5.1 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6 Spain
7.4.6.1 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7 Sweden
7.4.7.1 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.8 Denmark
7.4.8.1 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.9 Norway
7.4.9.1 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2 Japan
7.5.2.1 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3 China
7.5.3.1 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4 India
7.5.4.1 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5 South Korea
7.5.5.1 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6 Singapore
7.5.6.1 Singapore Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7 Australia
7.5.7.1 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8 Thailand
7.5.8.1 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6 Latin America
7.6.1 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2 Brazil
7.6.2.1 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3 Argentina
7.6.3.1 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7 MEA
7.7.1 MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2 South Africa
7.7.2.1 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.4 UAE
7.7.4.1 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.5 Kuwait
7.7.5.1 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Competitive Profiles
8.1 Ventec Life Systems, Inc. (Subsidiary of React Health - includes the Respiratory Product Line from Invacare Corporation)
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 Inogen, Inc.
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 IUC Medical (Smiths Medical)
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 HERSILL S.L.
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 OMRON Healthcare
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 GE Healthcare
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 Fisher & Paykel Healthcare Limited
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Respironics (a subsidiary of Koninklijke Philips N.V.)
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.8.4 Strategic Initiatives
8.9 Tecno-Gaz Industries
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Allied Healthcare Products, Inc.
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
8.11 Teleflex Incorporated
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Product Benchmarking
8.11.4 Strategic Initiatives
8.12 Chart Industries
8.12.1 Company Overview
8.12.2 Financial Performance
8.12.3 Product Benchmarking
8.12.4 Strategic Initiatives
8.13 DeVilbiss Healthcare (a subsidiary of Drive Medical)
8.13.1 Company Overview
8.13.2 Financial Performance
8.13.3 Product Benchmarking
8.13.4 Strategic Initiatives
8.14 Drägerwerk AG & Co. KGaA
8.14.1 Company Overview
8.14.2 Financial Performance
8.14.3 Product Benchmarking
8.14.4 Strategic Initiatives
8.15 Linde
8.15.1 Company Overview
8.15.2 Financial Performance
8.15.3 Product Benchmarking
8.15.4 Strategic Initiatives
8.16 Caire Medical (Acquired by Niterra Co., Ltd. formerly known as NGK SPARK PLUG CO., LTD.)
8.16.1 Company Overview
8.16.2 Financial Performance
8.16.3 Product Benchmarking
8.16.4 Strategic Initiatives
8.17 Rhythm Healthcare
8.17.1 Company Overview
8.17.2 Financial Performance
8.17.3 Product Benchmarking
8.17.4 Strategic Initiatives
8.18 ResMed
8.18.1 Company Overview
8.18.2 Financial Performance
8.18.3 Product Benchmarking
8.18.4 Strategic Initiatives
Chapter 9 Competitive Landscape
9.1 Exit Strategies of Existing Market Players and Their Impact on Market Competitors
9.1.1. Invacare Corporation
9.1.2. Koninklijke Philips N.V.
9.2 Estimated Company Market Position/Share Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings